Patents for A61P 27 - Drugs for disorders of the senses (53,017)
02/2012
02/16/2012US20120041024 Quinolyl amines as kinase inhibitors
02/16/2012US20120041023 Small molecule activators of mitochondrial function
02/16/2012US20120041017 Pyridocarbazole type compounds and applications thereof
02/16/2012US20120041010 Pharmaceutical combination of (e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl] (3r,5s)-3,5-dihydroxyhept-6-enoic acid and candesartan
02/16/2012US20120040997 Vinyl-aryl derivatives for inflammation and immune-related uses
02/16/2012US20120040994 THERAPEUTIC AGENT FOR GLAUCOMA COMPRISING Rho KINASE INHIBITOR AND PROSTAGLANDIN
02/16/2012US20120040987 Derivatives of 6-(6-nh-substituted-triazolopyridazine-sulfanyl) benzothiazoles and benzimidazoles, preparation thereof, use thereof as drugs, and use thereof as met inhibitors
02/16/2012US20120040964 N-substituted piperidines and their use as pharmaceuticals
02/16/2012US20120040956 Inhibitors of hif-1 protein accumulation
02/16/2012US20120040933 9-(piperazinylalkyl) carbazoles as bax-modulators
02/16/2012US20120040923 Stable s-adenosyl-l-methionine
02/16/2012US20120040897 Novel derivatives of acyl cyanopyrrolidines
02/16/2012US20120040884 Methods and Reagents for Treatment and Diagnosis of Vascular Disorders and Age-Related Macular Degeneration
02/16/2012US20120040014 LIPID Supplements for Maintaining Health and Treatment of Acute and Chronic Disorders
02/16/2012US20120040012 Therapeutic stem cell nutrient composition and uses thereof
02/16/2012US20120040007 Serine palmitoyltransferase inhibitors for preventing and delaying retinitis pigmentosa
02/16/2012US20120039986 Compositions and methods for sirna inhibition of angiopoietin 1 and 2 and their receptor tie2
02/16/2012US20120039982 Bio-Sheet for Eye Tissue Repair
02/16/2012US20120039927 Use of extracts of pezizaceae in the prevention and/or treatment of senile cataracts
02/16/2012US20120039913 Selective Histamine H4 Receptor Antagonists for the Treatment of Vestibular Disorders
02/16/2012US20120039911 Cd93 or use of soluble fragment thereof
02/16/2012US20120039896 Method for inhibiting cellular activation by insulin-like growth factor-1
02/16/2012US20120039883 Detection and diagnosis of inflammatory disorders
02/16/2012US20120039839 Hypoxia Induced Mitogenic Factor
02/16/2012US20120039801 SPARC binding peptides and uses thereof
02/16/2012CA2843684A1 Compositions, kits and methods for treatment of complement-related disorders
02/16/2012CA2807858A1 Injectable pharmaceutical composition for preventing, stabilising and/or inhibiting pathological neovascularization-related conditions
02/16/2012CA2807628A1 Methods and pharmaceutical compositions for the treatment of an ocular disease in a subject
02/15/2012EP2418279A1 Injectable pharmaceutical composition for preventing, stabilising and/or inhibiting pathological neovascularization-related conditions
02/15/2012EP2117553B8 Compositions for treating, reducing, ameliorating, or preventing infections of the ear or upper respiratory tract
02/15/2012EP1601362B1 Use of diazoxide in the treatment of ischemia retinae
02/15/2012CN1918127B 具有引入了取代或无取代氨基的4-吡啶基烷硫基的环状化合物 The introduction of a cyclic compound having a substituted or unsubstituted 4-pyridyl amino alkylthio
02/15/2012CN102351934A Steroidal alkaloid compounds and pharmaceutical composition thereof, as well as preparation methods and applications of steroidal alkaloid compounds and pharmaceutical composition of compounds
02/15/2012CN102349926A New medical application of combination of paeonol, derivative thereof and paeoniflorin
02/15/2012CN102349910A Compound medicinal composition for ophthalmology and preparation method thereof
02/15/2012CN102091212B 一种治疗复发性中心性浆液性脉络膜视网膜病的中药汤剂 A treatment for recurrent central serous retinopathy decoction
02/14/2012US8114999 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
02/14/2012US8114849 Retinal dystrophy-associated protein and uses thereof
02/14/2012US8114618 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays
02/14/2012CA2463154C Heterocyclic compounds and methods of use
02/14/2012CA2402160C Heparinase iii and uses thereof
02/09/2012WO2012017077A1 Combination of compounds for treating or preventing skin diseases
02/09/2012WO2012016930A1 Compound useful for the treatment of nonsense-mutation-mediated diseases and pharmaceutical composition comprising said compound
02/09/2012US20120035256 Use of bipolar trans carotenoids as a pretreatment and in the treatment of peripheral vascular disease
02/09/2012US20120035250 Plasmalogen compounds, pharmaceutical compositions containing the same and methods for treating diseases of the aging
02/09/2012US20120035239 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
02/09/2012US20120035217 Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors
02/09/2012US20120035214 Renin inhibitors
02/09/2012US20120035207 Use of GABAA Receptor Agonists for the Treatment of Hearing, Vestibular and Attention Disorders, Intention Tremor and Restless Leg Syndrome
02/09/2012US20120035187 Anti-neurodegenerative disease agent
02/09/2012US20120035179 Modulators of atp-binding cassette transporters
02/09/2012US20120035175 Novel salts as Anti-Inflammatory, Immunomodulatory and Anti-Proliferatory Agents
02/09/2012US20120035168 N-((6-amino-pyridin-3-yl)methyl)-heteroaryl-carboxamides
02/09/2012US20120035159 Substituted isoquinoline derivative
02/09/2012US20120035154 Modulators of Cellular Adhesion
02/09/2012US20120035150 Mif inhibitors and their uses
02/09/2012US20120035148 Ophthalmic compositions and methods for treating ophthalmic conditions
02/09/2012US20120035147 Method for treatment of diseases
02/09/2012US20120035146 Implants and methods for treating inflammation-mediated conditions of the eye
02/09/2012US20120035140 Carbamoylphosphonates as inhibitors and uses thereof
02/09/2012US20120034321 Nitric oxide enhancing prostaglandin compounds, compositions and methods of use
02/09/2012US20120034303 Pharmaceutical formulation comprising one or more fumaric acid esters in an erosion matrix
02/09/2012US20120034279 Transscleral delivery
02/09/2012US20120034274 Pharmaceutical composition comprising one or more fumaric acid esters
02/09/2012US20120034201 Composition for regulating lipid metabolism
02/09/2012US20120034193 Treatment of neurotrophic factor mediated disorders
02/09/2012CA2810267A1 Combination of compounds for treating or preventing skin diseases
02/09/2012CA2807537A1 Combined drug delivery methods and apparatus
02/09/2012CA2807508A1 Subconjunctival implant for posterior segment drug delivery
02/09/2012CA2807376A1 Collagen-based implants for sustained delivery of drugs
02/09/2012CA2806825A1 Compound useful for the treatment of nonsense-mutation-mediated diseases and pharmaceutical composition comprising said compound
02/08/2012EP2415763A1 Pharmaceutical composition for treating or preventing glaucoma
02/08/2012EP2415755A1 Plasminogen activator inhibitor-1 inhibitor
02/08/2012EP2415478A1 Prophylactic or therapeutic agent for retinal diseases and method for preventing or treating retinal diseases, each comprising jnk (c-jun n-terminal kinase)-inhibiting peptide, and use of the peptide
02/08/2012EP2415474A1 Pharmaceutical composition for treatment or prevention of ophthalmic diseases
02/08/2012EP2415468A1 Composition for alleviating ultraviolet radiation-induced damage
02/08/2012EP2414330A2 Piperidine and piperazine derivatives as autotaxin inhibitors
02/08/2012CN102348714A Steroid compound
02/08/2012CN102348683A Prophylactic or therapeutic agent for optic nerve disorders comprising 4,6-dichloro-1h-indole-2-carboxylic acid derivative or salt thereof as active ingredient
02/08/2012CN102348456A Use of deferiprone for treatment and prevention of iron-related eye disorders
02/08/2012CN102344416A Pyridazine derivative and application thereof serving as anti-small RNA (Ribose Nucleic Acid) virus infection medicament
02/08/2012CN102343050A Eye ointment for treating eye diseases
02/08/2012CN102343040A Drug for treating otitis media, deaf and tinnitus
02/08/2012CN102343030A Method for treating vitreous opacity with Chinese herbal medicines
02/08/2012CN102343012A Composition for treating ophthalmic diseases and its preparation method
02/08/2012CN102342982A Traditional Chinese medicine for expelling wind, improving eyesight and treating conjunctivitis and preparation method of same
02/08/2012CN102342967A Thin film coated tablets containing vitamin, ginseng and zinc sulfate and preparation method thereof
02/08/2012CN102342957A Powder for otitis media and preparation method thereof
02/08/2012CN102342941A Ophthalmic and otic compositions of facially amphiphilic polymers and oligomers
02/08/2012CN102342938A Methods and compositions for treatment and management of cancers
02/08/2012CN102342925A Compositions for treating infection in cattle and swine
02/08/2012CN102342911A Ganciclovir eye drops and preparation method thereof
02/08/2012CN102342908A 胶原蛋白角膜 Corneal Collagen
02/08/2012CN101384704B 可再吸收的角膜扣状体 Resorbable corneal button-shaped body
02/08/2012CN101180082B 利用siv-pedf载体治疗伴随眼组织细胞凋亡变性的疾患的药物 Use siv-pedf vehicle treated apoptotic degeneration associated with ocular tissue disorders drug
02/07/2012US8110177 Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
02/07/2012CA2486144C Compositions comprising an angiotensin receptor blocker, a calcium channel blocker and a diuretic
02/07/2012CA2471046C Treatment of faecal incontinence and other conditions with 1r, 2s-methoxamine
02/07/2012CA2452923C Peptide-based compounds for targeting integrin receptors
02/02/2012WO2012016162A2 Compositions, methods and kits for modeling, diagnosing, and treating complement disorders
1 ... 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 ... 531